Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
QuidelOrtho (QDEL)
NASDAQ:QDEL
QuidelOrtho (QDEL) Stock Price & Analysis
1,704 Followers
QDEL Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$29.74 - $89.11
Previous Close$34.69
Volume914.95K
Average Volume (3M)956.26K
Market Cap
$2.32B
Enterprise Value$4.74B
Total Cash (Recent Filing)$167.30M
Total Debt (Recent Filing)$2.59B
Price to Earnings (P/E)―
Beta1.02
Next Earnings
Jul 31, 2024EPS Estimate
-$0.23Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-26.38
Shares Outstanding66,971,816
10 Day Avg. Volume1,047,671
30 Day Avg. Volume956,264
Standard Deviation0.17
R-Squared0.00146
Alpha0.00935
Financial Highlights & Ratios
Price to Book (P/B)-5.61
Price to Sales (P/S)0.79
Price to Cash Flow (P/CF)7.30
P/FCF Ratio7.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.58
Enterprise Value/Gross Profit3.17
Enterprise Value/Ebitda20.26
Forecast
1Y Price Target
$46.50Price Target Upside34.04% Upside
Rating ConsensusHold
Number of Analyst Covering4
QuidelOrtho News
Bulls Say, Bears Say
Bulls Say
Cost SavingsPreviously announced $100 million in annualized cost savings are expected to be realized in the second half of 2024 and the first half of 2025.
Earnings1Q results came in above the Street expectations with total revenues of $711M.
Financial PerformanceThe company reported revenue of $711 million, which was higher than the consensus of $693 million.
Bears Say
GuidanceThe company suspended its 2024 guidance to allow the new CEO to assess the business.
Product LaunchQDEL formally withdrew its target of having Savanna RVP4 assay available for the 2024/2025 respiratory season.
Revenue ExpectationsThe company lowered its COVID revenue expectations from $225 million to $150 million year over year.
---
Ownership Overview
23.29% Insiders
33.00% Mutual Funds
18.99% Other Institutional Investors
24.72% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
QDEL FAQ
What was QuidelOrtho’s price range in the past 12 months?
QuidelOrtho lowest stock price was $29.73 and its highest was $89.11 in the past 12 months.
What is QuidelOrtho’s market cap?
Currently, no data Available
When is QuidelOrtho’s upcoming earnings report date?
QuidelOrtho’s upcoming earnings report date is Jul 31, 2024 which is in 9 days.
How were QuidelOrtho’s earnings last quarter?
QuidelOrtho released its earnings results on May 08, 2024. The company reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.39 by $0.05.
Is QuidelOrtho overvalued?
According to Wall Street analysts QuidelOrtho’s price is currently Undervalued.
Does QuidelOrtho pay dividends?
QuidelOrtho does not currently pay dividends.
What is QuidelOrtho’s EPS estimate?
QuidelOrtho’s EPS estimate is -$0.23.
How many shares outstanding does QuidelOrtho have?
QuidelOrtho has 66,971,820 shares outstanding.
What happened to QuidelOrtho’s price movement after its last earnings report?
QuidelOrtho reported an EPS of $0.44 in its last earnings report, beating expectations of $0.39. Following the earnings report the stock price went up 2.202%.
Which hedge fund is a major shareholder of QuidelOrtho?
Among the largest hedge funds holding QuidelOrtho’s share is Maverick Capital ltd. It holds QuidelOrtho’s shares valued at 65M.
---
QuidelOrtho Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$46.50 (34.04% Upside)
$46.50 (34.04% Upside)
Blogger Sentiment
Bullish
QDEL Sentiment 60%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 1.4M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 2.1%
Last 30 Days ▲ 10.6%
Last 30 Days ▲ 10.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-58.54%
12-Months-Change
Fundamentals
Return on Equity
-42.51%
Trailing 12-Months
Asset Growth
-23.71%
Trailing 12-Months
Company Description
QuidelOrtho
Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA.
---
QDEL Company Deck
---
QDEL Earnings Call
Q1 2024
0:00 / 0:00
---
QDEL Stock 12 Month Forecast
Average Price Target
$46.50
▲(34.04% Upside)
Technical Analysis
Best Analysts Covering QDEL
1 Year
1 Year Success Rate
0/13 ratings generated profit
1 Year Average Return
-27.15%
reiterated a buy rating 5 months ago
Copying Andrew Cooper's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -27.15% per trade.
---